These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 37104009)

  • 1. Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update.
    Bayraktar E; Bayraktar R; Oztatlici H; Lopez-Berestein G; Amero P; Rodriguez-Aguayo C
    Noncoding RNA; 2023 Apr; 9(2):. PubMed ID: 37104009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.
    Rupaimoole R; Slack FJ
    Nat Rev Drug Discov; 2017 Mar; 16(3):203-222. PubMed ID: 28209991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA as an Important Target for Anticancer Drug Development.
    Fu Z; Wang L; Li S; Chen F; Au-Yeung KK; Shi C
    Front Pharmacol; 2021; 12():736323. PubMed ID: 34512363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA: Promising Roles in Cancer Therapy.
    Hashemi A; Gorji-Bahri G
    Curr Pharm Biotechnol; 2020; 21(12):1186-1203. PubMed ID: 32310047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNAi-based therapeutics and tumor targeted delivery in cancer.
    Kara G; Calin GA; Ozpolat B
    Adv Drug Deliv Rev; 2022 Mar; 182():114113. PubMed ID: 35063535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The crosstalk between miRNAs and signaling pathways in human cancers: Potential therapeutic implications.
    Shekhar R; Kumari S; Vergish S; Tripathi P
    Int Rev Cell Mol Biol; 2024; 386():133-165. PubMed ID: 38782498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments.
    To KKW; Fong W; Tong CWS; Wu M; Yan W; Cho WCS
    Expert Opin Drug Discov; 2020 Jan; 15(1):63-83. PubMed ID: 31739699
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment.
    Raue R; Frank AC; Syed SN; Brüne B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel approaches in cancer treatment: preclinical and clinical development of small non-coding RNA therapeutics.
    Cuciniello R; Filosa S; Crispi S
    J Exp Clin Cancer Res; 2021 Dec; 40(1):383. PubMed ID: 34863235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Targeting of microRNAs in Cancer: Future Perspectives.
    Tutar L; Tutar E; Özgür A; Tutar Y
    Drug Dev Res; 2015 Nov; 76(7):382-8. PubMed ID: 26435382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging roles for modulation of microRNA signatures in cancer chemoprevention.
    Neelakandan K; Babu P; Nair S
    Curr Cancer Drug Targets; 2012 Jul; 12(6):716-40. PubMed ID: 22515522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic potential of microRNAs in cancer.
    Thorsen SB; Obad S; Jensen NF; Stenvang J; Kauppinen S
    Cancer J; 2012; 18(3):275-84. PubMed ID: 22647365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic targeting of non-coding RNAs in cancer.
    Slaby O; Laga R; Sedlacek O
    Biochem J; 2017 Dec; 474(24):4219-4251. PubMed ID: 29242381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A step-by-step microRNA guide to cancer development and metastasis.
    Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
    Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profile of MicroRNA: An Emerging Hallmark of Cancer.
    Zaheer U; Faheem M; Qadri I; Begum N; Yassine HM; Al Thani AA; Mathew S
    Curr Pharm Des; 2019; 25(6):642-653. PubMed ID: 30914015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance and Applications in Human Triple-Negative Breast Cancer.
    Ding L; Gu H; Xiong X; Ao H; Cao J; Lin W; Yu M; Lin J; Cui Q
    Cells; 2019 Nov; 8(12):. PubMed ID: 31766744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of miRNAs in Cancer Diagnostics and Therapy: A Recent Update.
    Sayyed AA; Gondaliya P; Bhat P; Mali M; Arya N; Khairnar A; Kalia K
    Curr Pharm Des; 2022; 28(6):471-487. PubMed ID: 34751112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs: master regulators of drug resistance, stemness, and metastasis.
    Raza U; Zhang JD; Sahin O
    J Mol Med (Berl); 2014 Apr; 92(4):321-36. PubMed ID: 24509937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting Nanotechnology for the Development of MicroRNA-Based Cancer Therapeutics.
    Tyagi N; Arora S; Deshmukh SK; Singh S; Marimuthu S; Singh AP
    J Biomed Nanotechnol; 2016 Jan; 12(1):28-42. PubMed ID: 27301170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.